基于可解释深度学习神经模型PASNet的系统性红斑狼疮疾病特征基因挖掘与分析
Mining and Analysis of Systemic Lupus Erythematosus Disease Characteristic Genes Based on Interpretable Deep Learning Neural Model PASNet Combined with Bioinformatics
DOI: 10.12677/acm.2025.1541247, PDF,    国家自然科学基金支持
作者: 张瑀欣, 周旭丹, 孙向荣, 郭 爽, 侯燕燕, 罗 金, 陈长龙, 马国辉, 舒 伟*:桂林医学院智能医学与生物技术学院,广西 桂林;杨清琳:广西国际商务职业技术学院数学艺术学院,广西 南宁
关键词: 深度学习生物信息学转录组系统性红斑狼疮Deep Learning Bioinformatics Transcriptome Systemic Lupus Erythematosus
摘要: 目的:通过可解释深度学习神经模型(pathway-associated sparse deep neural network, PASNet)结合生物信息学方法寻找系统性红斑狼疮疾病的特征基因。方法:从NCBI的GEO数据库收集SLE外周血转录组数据,使用R语言筛选差异基因用于模型训练。基于PASNet模型构建用于SLE疾病研究的信号通路相关深度学习神经网络模型,获得SLE疾病相关的关键基因和关键通路。LASSO回归和随机森林方法进一步筛选疾病特征基因。验证SLE疾病特征基因在外部数据集上的表达情况并验证特征基因的临床诊断效果。结果:构建的神经网络模型在深度学习训练后,测试集上验证的预测效果较好,ROC曲线下面积(area under the curve, AUC)为0.82。模型获得47个疾病相关的关键基因,进一步机器学习算法分析及GSE61635数据验证筛选出ADHFE1、BCL11B、BLVRA和BOLAL四种SLE疾病特征基因。SLE单细胞数据验证结果显示,BCL11B和BLVRA基因与免疫细胞有不同程度的相关性,用其构建的临床诊断模型能很好地区分疾病。结论:通过深度学习结合生物信息学方法筛选的BCL11B和BLVRA基因可作为SLE的潜在生物标志物进一步研究。
Abstract: Objective: To identify characteristic genes of SLE using an interpretable deep learning neural model (PASNet) combined with bioinformatics methods. Methods: SLE peripheral blood transcriptome data were collected from the GEO database of NCBI, and differentially expressed genes were screened using R language for model training. A pathway-associated deep learning neural network model based on PASNet was constructed for SLE disease research to identify key genes and pathways related to SLE. LASSO regression and random forest methods were further employed to screen disease characteristic genes. The expression of these characteristic genes in external datasets was validated, and their clinical diagnostic efficacy was evaluated. Results: The constructed neural network model demonstrated good predictive performance on the test set after deep learning training, with an area under the ROC curve (AUC) of 0.82. The model identified 47 disease-related key genes, and machine learning algorithms analyze and GSE61635 data validation further screened out four SLE characteristic genes: ADHFE1, BCL11B, BLVRA, and BOLAL. SLE single-cell data validation results showed that BCL11B and BLVRA genes were correlated with immune cells to varying degrees, and the clinical diagnostic model constructed using these genes effectively distinguished the disease. Conclusion: The BCL11B and BLVRA genes screened through deep learning combined with bioinformatics methods can serve as potential biomarkers for SLE and warrant further research.
文章引用:张瑀欣, 周旭丹, 杨清琳, 孙向荣, 郭爽, 侯燕燕, 罗金, 陈长龙, 马国辉, 舒伟. 基于可解释深度学习神经模型PASNet的系统性红斑狼疮疾病特征基因挖掘与分析[J]. 临床医学进展, 2025, 15(4): 2834-2846. https://doi.org/10.12677/acm.2025.1541247

参考文献

[1] Accapezzato, D., Caccavale, R., Paroli, M.P., Gioia, C., Nguyen, B.L., Spadea, L., et al. (2023) Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 24, Article 6578. [Google Scholar] [CrossRef] [PubMed]
[2] Tsokos, G.C. (2020) Autoimmunity and Organ Damage in Systemic Lupus Erythematosus. Nature Immunology, 21, 605-614. [Google Scholar] [CrossRef] [PubMed]
[3] Herrada, A.A., Escobedo, N., Iruretagoyena, M., Valenzuela, R.A., Burgos, P.I., Cuitino, L., et al. (2019) Innate Immune Cells’ Contribution to Systemic Lupus Erythematosus. Frontiers in Immunology, 10, Article 772. [Google Scholar] [CrossRef] [PubMed]
[4] Siegel, C.H. and Sammaritano, L.R. (2024) Systemic Lupus Erythematosus: A Review. JAMA, 331, 1480-1491. [Google Scholar] [CrossRef] [PubMed]
[5] Parodis, I. and Sjöwall, C. (2024) Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 25, Article 9965. [Google Scholar] [CrossRef] [PubMed]
[6] Yin, X., Kim, K., Suetsugu, H., Bang, S., Wen, L., Koido, M., et al. (2021) Meta-Analysis of 208370 East Asians Identifies 113 Susceptibility Loci for Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 80, 632-640. [Google Scholar] [CrossRef] [PubMed]
[7] Fazel-Najafabadi, M., Looger, L., Reddy-Rallabandi, H., et al. (2023) A Multilayered Post-GWAS Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus (SLE). medRxiv: The Preprint Server for Health Sciences. [Google Scholar] [CrossRef] [PubMed]
[8] Ghodke-Puranik, Y., Olferiev, M. and Crow, M.K. (2024) Systemic Lupus Erythematosus Genetics: Insights into Pathogenesis and Implications for Therapy. Nature Reviews Rheumatology, 20, 635-648. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, T., Wang, H., Qiu, L., Wu, L., Ling, H., Xue, Y., et al. (2022) Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis. Journal of Immunology Research, 2022, Article 8140982. [Google Scholar] [CrossRef] [PubMed]
[10] Selvaraja, M., Chin, V.K., Abdullah, M., Arip, M. and Amin-Nordin, S. (2021) HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia. Frontiers in Medicine, 7, Article 598665. [Google Scholar] [CrossRef] [PubMed]
[11] Rauschert, S., Raubenheimer, K., Melton, P.E. and Huang, R.C. (2020) Machine Learning and Clinical Epigenetics: A Review of Challenges for Diagnosis and Classification. Clinical Epigenetics, 12, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
[12] Karim, M.R., Islam, T., Shajalal, M., Beyan, O., Lange, C., Cochez, M., et al. (2023) Explainable AI for Bioinformatics: Methods, Tools and Applications. Briefings in Bioinformatics, 24, bbad236. [Google Scholar] [CrossRef] [PubMed]
[13] Jiang, S.H., Athanasopoulos, V., Ellyard, J.I., Chuah, A., Cappello, J., Cook, A., et al. (2019) Functional Rare and Low Frequency Variants in BLK and BANK1 Contribute to Human Lupus. Nature Communications, 10, Article No. 2201. [Google Scholar] [CrossRef] [PubMed]
[14] Zhu, H., Mi, W., Luo, H., Chen, T., Liu, S., Raman, I., et al. (2016) Whole-Genome Transcription and DNA Methylation Analysis of Peripheral Blood Mononuclear Cells Identified Aberrant Gene Regulation Pathways in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 18, Article No. 162. [Google Scholar] [CrossRef] [PubMed]
[15] Nehar-Belaid, D., Hong, S., Marches, R., Chen, G., Bolisetty, M., Baisch, J., et al. (2020) Mapping Systemic Lupus Erythematosus Heterogeneity at the Single-Cell Level. Nature Immunology, 21, 1094-1106. [Google Scholar] [CrossRef] [PubMed]
[16] Hao, J., Kim, Y., Kim, T. and Kang, M. (2018) PASNet: Pathway-Associated Sparse Deep Neural Network for Prognosis Prediction from High-Throughput Data. BMC Bioinformatics, 19, Article No. 510. [Google Scholar] [CrossRef] [PubMed]
[17] Fabregat, A., Korninger, F., Viteri, G., Sidiropoulos, K., Marin-Garcia, P., Ping, P., et al. (2018) Reactome Graph Database: Efficient Access to Complex Pathway Data. PLOS Computational Biology, 14, e1005968. [Google Scholar] [CrossRef] [PubMed]
[18] Mandrekar, J.N. (2010) Receiver Operating Characteristic Curve in Diagnostic Test Assessment. Journal of Thoracic Oncology, 5, 1315-1316. [Google Scholar] [CrossRef] [PubMed]
[19] Sun, X., Shu, W., Zhang, Y., Huang, X., Liu, J., Liu, Y., et al. (2023) Identification of Alzheimer’s Disease Associated Genes through Explicable Deep Learning and Bioinformatic. 2023 IEEE 4th International Conference on Pattern Recognition and Machine Learning (PRML), Urumqi, 4-6 August 2023, 320-327. [Google Scholar] [CrossRef
[20] Zhang, Y., Sun, X., Zhang, P., Zhou, X., Huang, X., Zhang, M., et al. (2024) Identification of Parkinson’s Disease Associated Genes through Explicable Deep Learning and Bioinformatic. In: Huang, D.S., Premaratne, P. and Yuan, C., Eds., Communications in Computer and Information Science, Springer, 136-146. [Google Scholar] [CrossRef
[21] Kim, S.Y., Kang, H.T., Choi, H.R. and Park, S.C. (2011) Biliverdin Reductase A in the Prevention of Cellular Senescence against Oxidative Stress. Experimental and Molecular Medicine, 43, 15-23. [Google Scholar] [CrossRef] [PubMed]
[22] Vitek, L., Hinds, T.D., Stec, D.E. and Tiribelli, C. (2023) The Physiology of Bilirubin: Health and Disease Equilibrium. Trends in Molecular Medicine, 29, 315-328. [Google Scholar] [CrossRef] [PubMed]
[23] Canesin, G., Hejazi, S.M., Swanson, K.D. and Wegiel, B. (2020) Heme-Derived Metabolic Signals Dictate Immune Responses. Frontiers in Immunology, 11, Article 66. [Google Scholar] [CrossRef] [PubMed]
[24] Adin, C.A. (2021) Bilirubin as a Therapeutic Molecule: Challenges and Opportunities. Antioxidants, 10, Article 1536. [Google Scholar] [CrossRef] [PubMed]
[25] Hu, Z., Pei, G., Wang, P., Yang, J., Zhu, F., Guo, Y., et al. (2015) Biliverdin Reductase a (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured Kidney. International Journal of Molecular Sciences, 16, 22621-22635. [Google Scholar] [CrossRef] [PubMed]
[26] Gibbs, P.E.M., Miralem, T. and Maines, M.D. (2015) Biliverdin Reductase: A Target for Cancer Therapy? Frontiers in Pharmacology, 6, Article 119. [Google Scholar] [CrossRef] [PubMed]
[27] Lobo-Silva, D., Carriche, G.M., Castro, A.G., Roque, S. and Saraiva, M. (2016) Balancing the Immune Response in the Brain: IL-10 and Its Regulation. Journal of Neuroinflammation, 13, Article No. 297. [Google Scholar] [CrossRef] [PubMed]
[28] Hasan, S.N., Sharma, A., Ghosh, S., Hong, S., Roy-Chowdhuri, S., Im, S.-H., et al. (2019) Bcl11B Prevents Catastrophic Autoimmunity by Controlling Multiple Aspects of a Regulatory T Cell Gene Expression Program. Science Advances, 5, eaaw0706. [Google Scholar] [CrossRef] [PubMed]
[29] Wing, J.B., Tanaka, A. and Sakaguchi, S. (2019) Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer. Immunity, 50, 302-316. [Google Scholar] [CrossRef] [PubMed]
[30] Ono, M. (2020) Control of Regulatory T‐Cell Differentiation and Function by T‐Cell Receptor Signalling and Foxp3 Transcription Factor Complexes. Immunology, 160, 24-37. [Google Scholar] [CrossRef] [PubMed]
[31] García-Aznar, J.M., Alonso Alvarez, S. and Bernal del Castillo, T. (2024) Pivotal Role of BCL11B in the Immune, Hematopoietic and Nervous Systems: A Review of the Bcl11B-Associated Phenotypes from the Genetic Perspective. Genes & Immunity, 25, 232-241. [Google Scholar] [CrossRef] [PubMed]
[32] Naito, T., Tanaka, H., Naoe, Y. and Taniuchi, I. (2011) Transcriptional Control of T-Cell Development. International Immunology, 23, 661-668. [Google Scholar] [CrossRef] [PubMed]
[33] Drashansky, T.T., Helm, E.Y., Curkovic, N., Cooper, J., Cheng, P., Chen, X., et al. (2021) BCL11B Is Positioned Upstream of PLZF and Rorγt to Control Thymic Development of Mucosal-Associated Invariant T Cells and MAIT17 Program. iScience, 24, Article102307. [Google Scholar] [CrossRef] [PubMed]
[34] Drashansky, T.T., Helm, E., Huo, Z., Curkovic, N., Kumar, P., Luo, X., et al. (2019) Bcl11B Prevents Fatal Autoimmunity by Promoting Treg Cell Program and Constraining Innate Lineages in Treg Cells. Science Advances, 5, eaaw0480. [Google Scholar] [CrossRef] [PubMed]
[35] Wu, C., Fan, W., Yang, H., Chu, P., Liao, P., Chen, L., et al. (2023) Contribution of Genetic Variants Associated with Primary Immunodeficiencies to Childhood-Onset Systemic Lupus Erythematous. Journal of Allergy and Clinical Immunology, 151, 1123-1131. [Google Scholar] [CrossRef] [PubMed]